|
| 36218231 | Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma. | Mol Carcinog | 2023 |
| 37190159 | Perinucleolar Compartment (PNC) Prevalence as an Independent Prognostic Factor in Pediatric Ewing Sarcoma: A Multi-Institutional Study. | Cancers (Basel) | 2023 |
| 37047307 | Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. | Int J Mol Sci | 2023 |
| 34559922 | Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer. | Mol Carcinog | 2022 |
| 36276125 | Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly. | Front Oncol | 2022 |
| 35868306 | Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. | Cancer Cell | 2022 |
| 33305598 | Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review. | Nutr Cancer | 2021 |
| 33745223 | CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression. | Pharmacol Res Perspect | 2021 |
| 34976816 | Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice. | Front Oncol | 2021 |
| 34206989 | Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis. | Cells | 2021 |
| 34059639 | Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex. | Cell Death Dis | 2021 |
| 34022283 | Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression. | Cancer Lett | 2021 |
| 32313104 | Overcoming Wnt-β-catenin dependent anticancer therapy resistance in leukaemia stem cells. | Nat Cell Biol | 2020 |
| 31786131 | Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice. | Gastroenterology | 2020 |
| 31992775 | Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway. | Sci Rep | 2020 |
| 32094348 | Suppressing STAT5 signaling affects osteosarcoma growth and stemness. | Cell Death Dis | 2020 |
| 32740891 | A Phase I Study to Evaluate Two Doses of Wharton's Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease. | Stem Cell Rev Rep | 2020 |
| 30674533 | Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response. | Cancer Res | 2019 |
| 31442435 | The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice. | Gastroenterology | 2019 |
| 31608135 | Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone. | Oncotarget | 2019 |
| 30832788 | Progress in Drug Discovery in Academia and Persistent Challenges of "the Valley of Death". | Mayo Clin Proc | 2019 |
| 30914802 | MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential. | Nat Rev Urol | 2019 |
| 31113837 | Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs. | J Pharmacol Exp Ther | 2019 |
| 31025088 | Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis. | J Mol Med (Berl) | 2019 |
| 29458417 | Cooperative p16 and p21 action protects female astrocytes from transformation. | Acta Neuropathol Commun | 2018 |
| 30333627 | Functional genomic landscape of acute myeloid leukaemia. | Nature | 2018 |
| 29579058 | Comparative oncology approach to drug repurposing in osteosarcoma. | PLoS One | 2018 |
| 27863422 | In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma. | Oncotarget | 2017 |
| 28295989 | Pharmacokinetics of two 6-mercaptopurine liquid formulations in children with acute lymphoblastic leukemia. | Pediatr Blood Cancer | 2017 |
| 27536557 | Targeting p97 to Disrupt Protein Homeostasis in Cancer. | Front Oncol | 2016 |
| 26331352 | RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells. | Mol Carcinog | 2016 |
| 26673007 | Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. | Oncotarget | 2016 |
| 27677075 | Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis. | Oncotarget | 2016 |
| 27775703 | DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway. | Nat Cell Biol | 2016 |
| 25898813 | A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies. | Cancer Chemother Pharmacol | 2015 |
| 24273151 | Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies. | Am J Hematol | 2014 |
| 25122069 | Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor. | Mol Cancer Ther | 2014 |
| 23157466 | Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with multiple sclerosis. | Curr Med Res Opin | 2013 |
| 23657945 | Drug repurposing for gastrointestinal stromal tumor. | Mol Cancer Ther | 2013 |
| 23157467 | Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with multiple sclerosis. | Curr Med Res Opin | 2013 |
| 22246671 | Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnership. | Cancer Res | 2012 |
| 22532602 | CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. | Mol Cancer Ther | 2012 |
| 22521610 | Gender-specific reduction of hepatic Mrp2 expression by high-fat diet protects female mice from ANIT toxicity. | Toxicol Appl Pharmacol | 2012 |
| 22650244 | A novel, unusually efficacious duocarmycin carbamate prodrug that releases no residual byproduct. | J Med Chem | 2012 |
| 21366640 | The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy. | J Clin Pharm Ther | 2011 |
| 22009536 | Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers. | Cancer Res | 2011 |
| 21511957 | New sources of drugs for hematologic malignancies. | Blood | 2011 |
| 20026673 | Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor: structure optimization and pharmacokinetics. | J Pharmacol Exp Ther | 2010 |
| 20942408 | Design, synthesis, and evaluation of duocarmycin O-amino phenol prodrugs subject to tunable reductive activation. | J Med Chem | 2010 |
| 18020335 | A unique class of duocarmycin and CC-1065 analogues subject to reductive activation. | J Am Chem Soc | 2007 |